Medtronic: Medtronic Announces FDA Classification of Deep Brain Stimulation Lead Cap Communication

In keeping with its commitment to keep physicians informed about product performance and safety, Medtronic, Inc. (NYSE: MDT ) issued an Urgent Medical Device Correction notification in February 2013 to provide physicians with information concerning the potential for deep brain stimulation (DBS) lead damage associated with the use of the lead cap provided in